Abbott Laboratories (ABT) Stock Price

ABTStock
$112.4714.39%52W
Market Cap$194.62B
P/E29.54x
PEG Ratio2.34
Div yield1.98%
Beta0.58

ABT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-13.77%
Price vs S&P 500 (4W)3.45%
PEG Ratio2.34
VGM Score48.67
P/E Ratio (Annual)29.54x
Indicated Dividend Yield (Annual)1.98%

ABT Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.28$1.31+2.61%(+$0.03)
Q1 2026$1.15$1.15+0.33%(+$0.00)
Q4 2025$1.49$1.50+0.34%(+$0.01)
Q3 2025$1.30$1.30+0.05%(+$0.00)

ABT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.00
4.03
4.06

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ABTAbbott Laboratories
CCC$112.47
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69
BMYBristol-Myers Squibb Co.BBB$66.58

About Abbott Laboratories

Abbott is a diversified healthcare company with leading products in cardiovascular devices, diabetes care, diagnostics, and nutrition. The company manufactures pacemakers, defibrillators, continuous glucose monitors, diagnostic testing equipment, and infant nutritional products. Approximately 60% of sales come from international markets, providing significant geographic diversification.